SG Americas Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-414,874
Closed -$42.1M 3378
2025
Q4
$42.1M Buy
414,874
+384,628
+1,272% +$30.9M 0.05% 260
2025
Q3
$1.66M Buy
30,246
+14,083
+87% +$704K 0.01% 1056
2025
Q2
$859K Buy
16,163
+514
+3% +$26.1K ﹤0.01% 1276
2025
Q1
$677K Buy
+15,649
New +$792K ﹤0.01% 1523
2024
Q4
Sell
-6,916
Closed -$471K 3278
2024
Q3
$471K Buy
6,916
+2,496
+56% +$141K ﹤0.01% 1737
2024
Q2
$187K Sell
4,420
-9,592
-68% -$528K ﹤0.01% 2201
2024
Q1
$968K Buy
+14,012
New +$886K ﹤0.01% 1149
2023
Q4
Sell
-8,723
Closed -$595K 3205
2023
Q3
$595K Sell
8,723
-1,370
-14% -$116K 0.01% 1636
2023
Q2
$948K Buy
10,093
+6,273
+164% +$489K 0.01% 1081
2023
Q1
$259K Sell
3,820
-10,303
-73% -$662K ﹤0.01% 2223
2022
Q4
$699K Buy
+14,123
New +$577K 0.01% 1242
2022
Q3
Sell
-77,107
Closed -$3.04M 3290
2022
Q2
$3.04M Sell
77,107
-37,708
-33% -$2.02M 0.03% 521
2022
Q1
$8.03M Buy
114,815
+112,052
+4,055% +$8.19M 0.06% 267
2021
Q4
$215K Sell
2,763
-6,432
-70% -$568K ﹤0.01% 2633
2021
Q3
$878K Sell
9,195
-58,527
-86% -$6.18M ﹤0.01% 2017
2021
Q2
$8.42M Buy
67,722
+66,576
+5,809% +$7.95M 0.04% 412
2021
Q1
$151K Sell
1,146
-2,594
-69% -$355K ﹤0.01% 2851
2020
Q4
$496K Sell
3,740
-4,222
-53% -$511K ﹤0.01% 1997
2020
Q3
$812K Buy
7,962
+183
+2% +$15.8K 0.01% 1320
2020
Q2
$676K Sell
7,779
-10,465
-57% -$836K 0.01% 1797
2020
Q1
$1.06M Buy
18,244
+11,721
+180% +$952K 0.01% 1247
2019
Q4
$603K Sell
6,523
-19,568
-75% -$1.72M 0.01% 1617
2019
Q3
$2.36M Buy
26,091
+3,995
+18% +$455K 0.02% 854
2019
Q2
$2.61M Buy
22,096
+17,355
+366% +$1.75M 0.02% 856
2019
Q1
$411K Buy
4,741
+2,207
+87% +$188K ﹤0.01% 2001
2018
Q4
$160K Sell
2,534
-14,116
-85% -$969K ﹤0.01% 2496
2018
Q3
$1.31M Sell
16,650
-116,076
-87% -$7.57M 0.01% 1485
2018
Q2
$7.94M Buy
132,726
+106,147
+399% +$5.71M 0.07% 283
2018
Q1
$1.07M Buy
+26,579
New +$1.3M 0.01% 1295
2017
Q4
Sell
-3,886
Closed -$183K 3321
2017
Q3
$183K Buy
+3,886
New +$156K ﹤0.01% 2656
2017
Q1
Sell
-21,372
Closed -$286K 3353
2016
Q4
$286K Sell
21,372
-2,203
-9% -$35.6K ﹤0.01% 2072
2016
Q3
$438K Buy
+23,575
New +$415K ﹤0.01% 1821
2015
Q4
Sell
-12,957
Closed -$233K 2775
2015
Q3
$233K Buy
12,957
+8,195
+172% +$188K ﹤0.01% 1358
2015
Q2
$142K Sell
4,762
-2,997
-39% -$75.3K ﹤0.01% 2165
2015
Q1
$171K Sell
7,759
-7,692
-50% -$195K ﹤0.01% 1968
2014
Q4
$424K Buy
15,451
+1,327
+9% +$32.3K ﹤0.01% 1767
2014
Q3
$274K Sell
14,124
-18,595
-57% -$341K ﹤0.01% 1817
2014
Q2
$557K Buy
32,719
+23,307
+248% +$321K ﹤0.01% 1632
2014
Q1
$133K Buy
+9,412
New +$127K ﹤0.01% 2102
2013
Q4
Sell
-18,313
Closed -$216K 2736
2013
Q3
$216K Buy
+18,313
New +$235K ﹤0.01% 2131

Other funds holding EXAS

SG Americas Securities's EXAS Position: Q1 2026 in Review

SG Americas Securities sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 414,874 shares — an estimated $42.1M sold.

SG Americas Securities first reported a position in EXAS in Q3 2013 and held it in 40 quarters. The position peaked at $42.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • SG Americas Securities reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 414,874 Exact Sciences shares in Q1 2026, an estimated $42.1M.
  • SG Americas Securities first reported a position in Exact Sciences in Q3 2013 and held it in 40 quarters.
  • SG Americas Securities's Exact Sciences position peaked at $42.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.